Quantcast

Latest Crohn's disease Stories

2014-09-18 04:21:05

Company Recently Initiated Phase II in Bullous Pemphigoid CAMBRIDGE, Mass. and HERZLIYA PITUACH, Israel, Sept. 18, 2014 /PRNewswire/ -- Immune Pharmaceuticals Inc. (NASDAQ: IMNP; "Immune" or "the Company") announces today that it has initiated the screening of patients for a Phase II proof of concept clinical trial exploring the safety and efficacy of bertilimumab in the treatment of ulcerative colitis (UC). Dr. Daniel Teper, Chairman and CEO of Immune comments: "Bertilimumab is...

crohns research
2014-08-28 03:00:17

Jen Middleton, University of Edinburgh Genetic changes that occur in patients with the bowel condition Crohn's disease could hold clues to fighting the illness. Scientists have identified chemical changes in the DNA of patients with Crohn's disease that could help to screen people for the disease. These changes can be detected in blood samples, opening the door to a simple test for Crohn's disease. The findings also offer clues to how the condition develops and reveal possible...

2014-08-22 12:25:46

At Weinberg Gastrointestinal, patients can now receive both American and Canadian screening colonoscopies in Gilbert, Arizona GILBERT, Ariz., Aug. 22, 2014 /PRNewswire-iReach/ -- Colon health is a big deal for patients in North America, which is why Dr. Andrew M Weinberg is now offering both Canadian and American screening colonoscopies to patients. The screening guidelines are slightly different in these countries.Gilbert, AZ gastroenterologist Dr. Andrew M Weinberg, DO is a...

2014-08-22 12:25:45

Dr. Glenn Madokoro educates patients on the signs of when it's probably a good time to make an appointment for a checkup at his Newport Beach, CA gastroenterology practice. NEWPORT BEACH, Calif., Aug. 22, 2014 /PRNewswire-iReach/ -- A lot of people hesitate to schedule an appointment with a doctor or specialist simply because they aren't sure when symptoms are serious enough to warrant a visit. Dr. Glenn D Madokoro, MD is educating patients on when it's a good idea to visit a...

2014-08-20 16:23:24

NEW YORK, Aug. 20, 2014 /PRNewswire/ -- Acclaimed Actress Amy Brenneman may play a silenced police chief's wife in her new role on "The Leftovers," but she generously lends her voice to help raise awareness for Crohn's disease and ulcerative colitis in a newly refreshed public service awareness campaign. To view the multimedia assets associated with this release, please click...

2014-08-20 08:28:32

The Crohn's & Colitis Foundation of America Teams Up with Pfizer Inc.'s Centers for Therapeutic Innovation to Support Novel Translational Research in Inflammatory Bowel Disease NEW YORK, Aug. 20, 2014 /PRNewswire-USNewswire/ -- The Crohn's & Colitis Foundation of America (CCFA) announces an agreement with Pfizer Inc.'s Centers for Therapeutic Innovation (CTI) to identify and support the potential development and translation of research in the area of inflammatory bowel disease...

2014-08-12 08:31:26

Study Aims To Enroll 10,000 Individuals With Inflammatory Bowel Disease MOUNTAIN VIEW, Calif., Aug. 12, 2014 /PRNewswire/ -- 23andMe, the leading personal genetics company today announced an agreement with Pfizer Inc. in which the companies will aim to enroll 10,000 people with Inflammatory Bowel Disease (IBD) in a research initiative designed to explore the genetic factors associated with the onset, progression, severity and response to treatments for IBD. Approximately 1.4...

2014-08-01 08:26:41

NEW YORK, Aug. 1, 2014 /PRNewswire/ -- Beginning on August 1, 2014, Crohn's and Colitis Awareness Month will be observed for the first time in New York State thanks to a resolution passed by the New York State legislature in June, reported the Crohn's & Colitis Foundation of America (CCFA). There are more than 1.4 million Americans living with Crohn's disease and ulcerative colitis, which are known collectively as inflammatory bowel diseases (IBD). "We applaud Governor Andrew...

2014-08-01 08:26:07

Awarded $2.1 million in additional funding PRINCETON, N.J., Aug. 1, 2014 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that the National Institute of Allergy and Infectious Diseases (NIAID) has exercised its option to...

2014-07-29 16:26:15

Researchers Look to Target Gut Microbiome for Treatment and Prevention of Crohn's Disease and Ulcerative Colitis NEW YORK, July 29, 2014 /PRNewswire/ -- Early findings from a major research initiative of the Crohn's & Colitis Foundation of America (CCFA) suggest that specific bacteria play a central role in Crohn's disease and ulcerative colitis (UC), also known as inflammatory bowel diseases (IBD). The evidence raises the possibility of developing new treatments to target the...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related